- Home
- STAA vs PEB Comparison
STAA vs PEB Comparison
Compare STAA & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- PEB
- Stock Information
- Founded
- STAA 1982
- PEB 2009
- Country
- STAA United States
- PEB United States
- Employees
- STAA N/A
- PEB N/A
- Industry
- STAA Ophthalmic Goods
- PEB Real Estate Investment Trusts
- Sector
- STAA Health Care
- PEB Real Estate
- Exchange
- STAA Nasdaq
- PEB Nasdaq
- Market Cap
- STAA 1.3B
- PEB 1.6B
- IPO Year
- STAA N/A
- PEB 2009
- Fundamental
- Price
- STAA $24.82
- PEB $13.56
- Analyst Decision
- STAA Buy
- PEB Buy
- Analyst Count
- STAA 7
- PEB 6
- Target Price
- STAA $42.83
- PEB $14.92
- AVG Volume (30 Days)
- STAA 615.8K
- PEB 1.8M
- Earning Date
- STAA 10-30-2024
- PEB 02-19-2025
- Dividend Yield
- STAA N/A
- PEB 0.30%
- EPS Growth
- STAA 9.97
- PEB N/A
- EPS
- STAA 0.44
- PEB N/A
- Revenue
- STAA $341,224,000.00
- PEB $1,449,797,000.00
- Revenue This Year
- STAA $8.37
- PEB N/A
- Revenue Next Year
- STAA $11.70
- PEB $3.64
- P/E Ratio
- STAA $56.42
- PEB N/A
- Revenue Growth
- STAA 10.01
- PEB 3.15
- 52 Week Low
- STAA $23.72
- PEB $11.65
- 52 Week High
- STAA $52.68
- PEB $16.65
- Technical
- Relative Strength Index (RSI)
- STAA 41.27
- PEB 44.96
- Support Level
- STAA $23.90
- PEB $13.25
- Resistance Level
- STAA $25.77
- PEB $14.73
- Average True Range (ATR)
- STAA 1.45
- PEB 0.44
- MACD
- STAA 0.01
- PEB -0.17
- Stochastic Oscillator
- STAA 27.23
- PEB 16.31
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,924 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.